{"result": "Here is a comprehensive summary of the data:\n\nThe \"I-SPY2 TRIAL\" is a clinical trial focused on breast cancer. Specifically, it is a phase 2 clinical trial that aims to evaluate the effect of pembrolizumab on the pathologic complete response (pCR) rate in high-risk stage II-III breast cancer patients.\n\nNote: I resolved the minor contradictions in the descriptions by combining the information to provide a clear and concise summary.", "input": "\nYou are a helpful assistant responsible for generating a comprehensive summary of the data provided below.\nGiven one or two entities, and a list of descriptions, all related to the same entity or group of entities.\nPlease concatenate all of these into a single, comprehensive description. Make sure to include information collected from all the descriptions.\nIf the provided descriptions are contradictory, please resolve the contradictions and provide a single, coherent summary.\nMake sure it is written in third person, and include the entity names so we the have full context.\n\n#######\n-Data-\nEntities: \"\\\"I-SPY2 TRIAL\\\"\"\nDescription List: [\"\\\"I-SPY2 TRIAL is a clinical trial on breast cancer.\\\"\", \"\\\"I-SPY2 Trial is a clinical trial on breast cancer.\\\"\", \"\\\"I-SPY2 trial is a phase 2 clinical trial evaluating the effect of pembrolizumab on pCR rate in high-risk stage II-III breast cancer.\\\"\"]\n#######\nOutput:\n", "parameters": {"model": "llama3-8b-8192", "temperature": 0.0, "frequency_penalty": 0.0, "presence_penalty": 0.0, "top_p": 1.0, "max_tokens": 500, "n": null}}